OpenResearchAlpha

Open Forum Infectious Diseases · 12 Nov 2026

Infectious Complications of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Metastatic Melanoma

Koray K Demirh-index 2, Alex N Zimmet, Anne Liu, Dora Ho, Allison Betof Warner, Aruna K Subramanianh-index 28

0
Citations
no database records one yet
0
Citations in 2026
so far
28
Leading author's h-index
Aruna K Subramanian, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract Background Tumor-infiltrating lymphocyte (TIL) therapy is a novel cellular immunotherapy approved for the treatment of metastatic melanoma. The infectious complications of TIL therapy are poorly understood. We aimed to describe the infections that occurred and the yield of diagnostic studies in patients who underwent TIL therapy at our institution. Methods We conducted a retrospective cohort study of patients who received TIL therapy at Stanford Healthcare between April 2024 and June 2025. Patient charts were reviewed to extract information on demographics as well as laboratory and clinical findings. Each case was reviewed to determine the presence or absence of infections. Results Thirty patients underwent TIL therapy during the study period. All patients developed neutropenia, of which 25 developed fevers. Investigations for causes of fever were rarely positive (including 0/149 blood cultures and 0/88 tests for fungal infections). False-positive results were more common than true positives. Patients received a median of 10 days of antipseudomonal antibiotics and frequently also received gram-positive coverage (n=11/25) and antifungal coverage (n=13/25). Six patients had documented infections, including intra-abdominal infections in 4 cases, possible superinfected tumor in 1 case, and CMV viremia with CMV colitis in 1 case. One patient developed Clostridioides difficile colitis following their receipt of systemic antibiotics. Conclusion Fever is common in patients undergoing TIL treatments, but most patients do not have documented infection. Extensive investigations rarely yield positive results. Opportunistic infections are uncommon but can occur, and clinicians should remain vigilant for this possibility, while carefully weighing the risks and benefits of specialized testing and empiric treatments.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Aruna K Subramanian has the highest h-index among the authors (28).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (6)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.